Similar articles

• Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.

  Villafranco JE, Lustigman AB. Villafranco JE, et al. Food Drug Law J. 2007;62(4):709-25. Food Drug Law J. 2007. PMID: 18557227 No abstract available.
• Disclaimers in dietary supplement print advertising: the bodybuilding category as a model case for change.

  Soller RW, Rice LG, Ambrose PJ. Soller RW, et al. Food Drug Law J. 2007;62(2):375-86. Food Drug Law J. 2007. PMID: 17632967 No abstract available.
• Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.

  Reichertz PS. Reichertz PS. Food Drug Law J. 1996;51(3):355-65. Food Drug Law J. 1996. PMID: 11797712 No abstract available.
• Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.

  Seamon MJ, Clauson KA. Seamon MJ, et al. J Herb Pharmacother. 2005;5(3):67-86. J Herb Pharmacother. 2005. PMID: 16520299 Review.
• Dietary supplements and lessons to be learned from GRAS.

  Burdock GA. Burdock GA. Regul Toxicol Pharmacol. 2000 Feb;31(1):68-76. doi: 10.1006/rtph.1999.1369. Regul Toxicol Pharmacol. 2000. PMID: 10715226 Review.